Novel epithelial tissue imaging agent
AssigneeEpicyte Pharmaceutical, Inc.
InventorsAndrew C. Hiatt, Mich B. Hein, John H. Fitchen
Life of this patent
Estimating the term…
Loading patent…
AssigneeEpicyte Pharmaceutical, Inc.
InventorsAndrew C. Hiatt, Mich B. Hein, John H. Fitchen
Estimating the term…
Targeting molecules are provided for use in delivering imaging agents to epithelial tissue. The targeting molecule comprises a polypeptide that forms a closed covalent loop, contains at least three peptide domains having β-sheet character, each of the domains being separated by domains lacking β-sheet character. The targeting molecule specifically binds to a basolateral factor attached to a basolateral domain of an epithelial cell surface causing internalization of a linked imaging agent into the cells. The polypeptide or imaging agent may be linked to a peptide amino acid sequence that directs delivery of the imaging agent to a carcinoma cell, a nucleus, or an endoplasmic reticulum.
A targeting molecule capable of specifically binding to a basolateral factor associated with an epithelial surface and causing the internalization of an imaging agent linked thereto, wherein the targeting molecule is not full length dimeric IgA.
A targeting molecule linked to at least one imaging agent, wherein said targeting molecule comprises a polypeptide that:
A targeting molecule linked to at least one imaging agent, wherein said targeting molecule comprises a polypeptide that:
A targeting molecule linked to at least one imaging agent, wherein said targeting molecule comprises a polypeptide that:
Dependencies are inferred from the claim text.